These three- to four-hour meetings will address the essential content outlined in the agenda, and often include state-specific policy and resource panels. These panels, modeled on our successful New England programming, consist of representatives from state and federal regulatory agencies — including, but not limited to, State Departments of Public Health (including the Prescription Drug Monitoring Program (PDMP) and addiction treatment services), regional Drug Enforcement Administration offices, State Licensing Boards, State Attorneys General and State Police. They bring information and resources to clinicians, and open a valuable dialogue between regulatory agencies and clinicians. The panel discussions have been invaluable and are intended to increase provider use of state programs and resources.GET STARTED NOW! Select a conference
Daniel P. Alford, MD, MPH, FACP, DFASAM
Professor of Medicine
Associate Dean, Continuing Medical Education, Boston University School of Medicine
Physicians, nurse practitioners, physician assistants, registered nurses, nurses, dentists, pharmacists and allied healthcare professionals
Chronic pain affects approximately 100 million in the US, making it one of the most common reasons for patients to seek medical care. Unfortunately, pain management, including the appropriate use of opioids, is not well covered in medical training. Moreover, there are inadequate numbers of pain management specialists to help generalist providers manage these patients.
Partly in response to the problem of under-treatment of pain, over the past decade there has been a four-fold increase in opioid prescribing. During the same time period there was a four-fold increase in unintentional opioid overdose deaths and a five-fold increase in substance abuse treatment admissions for prescription opioid addiction.
Providers who prescribe ER/LA opioid analgesics to treat chronic pain are in a key position to balance the benefits and risks of chronic opioid therapy (COT). However, providers struggle with the need to assist their patients with adequate management of chronic pain while confronting the risks associated with opioid prescribing. Our educational program looks to address that need. Strategies for multidisciplinary, inter-professional care are addressed in this curriculum.
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center?s Commission on Accreditation.
These activities are sponsored by Boston University School of Medicine in collaboration with the Council of Medical Specialty Societies (CMSS) and the Federation of State Medical Boards (FSMB). Our program addresses many key elements of the physician education component of the Obama Administration's prescription drug abuse prevention plan on prescriber education released in April 2011.
This educational activity is supported by an independent educational grant from the Extended-Release/Long-Acting Opioid Analgesic REMS Program Companies. Please see http://ce.er-la-opioidrems.com/IwgCEUI/rems/pdf/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Extended-Release/Long-Acting Opioid Analgesics REMS education requirements issued by the US Food & Drug Administration.
© 2018 Trustees of Boston University. Site by Signal.